Beyond the Screen-Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects

Affiliations

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
² Department of Pathology and Laboratory Medicine, Penn Medicine Lancaster General Health, Lancaster, PA, United States.
³ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
⁴ Departments of Pathology and Clinical and Translational Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
⁵ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.

Editorial

Christina C Pierre et al. Clin Chem. 2024.

. 2024 Dec 2;70(12):1494-1495.

doi: 10.1093/clinchem/hvae143.

¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
² Department of Pathology and Laboratory Medicine, Penn Medicine Lancaster General Health, Lancaster, PA, United States.
³ Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
⁴ Departments of Pathology and Clinical and Translational Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
⁵ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.

No abstract available

Comment on

The Inclusion of Race in Prenatal Screening Algorithms.
Norton ME, Risch N. Norton ME, et al. Clin Chem. 2024 Jul 5;70(7):891-893. doi: 10.1093/clinchem/hvae073. Clin Chem. 2024. PMID: 38842043 No abstract available.
Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects.
Messerlian G, Strickland SW, Willbur J, Vaughan C, Koenig S, Wright T, Palomaki GE. Messerlian G, et al. Clin Chem. 2024 Jul 5;70(7):948-956. doi: 10.1093/clinchem/hvae053. Clin Chem. 2024. PMID: 38965696
In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects.
Messerlian G, Palomaki GE. Messerlian G, et al. Clin Chem. 2024 Dec 2;70(12):1496. doi: 10.1093/clinchem/hvae154. Clin Chem. 2024. PMID: 39365157 No abstract available.